Neonatal Glycemic Control: Hypoglycemia Screening Protocols

Low blood glucose is one of the most common metabolic concerns during the newborn period. It can occur in a well-appearing baby, yet prolonged or severe hypoglycaemia may affect neurological development. A reliable screening protocol helps clinicians identify risk early, confirm concerning results and provide treatment without creating unnecessary separation from the parent.

For Australian maternity services, glucose monitoring needs to work across tertiary neonatal intensive care units, special care nurseries, postnatal wards and smaller rural hospitals. A protocol that is clear enough for a busy ward in Melbourne or Sydney must also support safe decisions when a newborn in regional Queensland requires advice from a retrieval service.

Neonatal glycaemic control is therefore a clinical process rather than a single blood glucose cut-off. It combines risk assessment, feeding support, accurate measurement, repeat testing, documented escalation and communication with families. The historic programme and scientific focus of the FAOPS congress site reflect the wider importance of perinatal and neonatal research in improving these practices.

Why Glucose Stability Matters

Newborns normally move from a continuous placental supply of glucose to intermittent feeding after birth. Their liver must release stored glycogen and produce glucose while feeding is established. Transitional changes are expected, but some babies cannot maintain an adequate concentration because of limited energy stores, excessive insulin or illness.

Important risk groups include infants of mothers with diabetes, preterm babies, small-for-gestational-age or growth-restricted infants, large-for-gestational-age infants and newborns who are unwell. Hypothermia, respiratory distress, sepsis, perinatal asphyxia and poor feeding can increase glucose use or reduce intake. A baby who appears settled may still have a low reading, while symptoms such as jitteriness, lethargy, apnoea, weak suck or seizures require immediate attention.

The aim is to avoid both under-treatment and over-intervention. Repeated heel pricks, formula supplementation or admission to a special care nursery can interfere with breastfeeding and parental bonding. Conversely, assuming that a quiet or sleepy baby is simply tired can delay treatment. Screening should be targeted, time-limited and linked to a defined action at each result.

Identifying Babies For Screening

Antenatal and birth information should be reviewed before the first postnatal assessment. Maternal diabetes, whether gestational, type 1 or type 2, should be visible in the handover. Birthweight, gestational age, growth percentile, feeding history, temperature and the circumstances of delivery help determine the monitoring plan.

Each service should state which infants require routine surveillance and when it begins. Many protocols monitor at-risk babies before the second feed, then before subsequent feeds until several acceptable pre-feed measurements are recorded. The exact duration varies with the risk factor and local policy. A late-preterm infant may need closer observation than a term infant who had one borderline result.

Australian hospitals also need a practical pathway for newborns transferred between settings. A baby born in a smaller Victorian or Western Australian unit may be stabilised locally before transport, while a family in the Northern Territory may face long distances and limited overnight services. The protocol should specify who is contacted, what information travels with the infant and how feeding and glucose results are handed over.

Timing And Measurement At The Cot Side

Screening is most useful when it is synchronised with feeding. Early skin-to-skin contact, a prompt first feed and regular assessment of latch or expressed colostrum support glucose stability. If the infant cannot feed effectively, staff should document the reason and consider expressed breast milk, donor milk, formula or intravenous therapy according to the clinical situation and local guidance.

Point-of-care blood glucose meters are convenient, but their accuracy can be limited at low concentrations, especially with poor peripheral perfusion, high haematocrit or an unusually low sample. A low or unexpected capillary result should be confirmed with a laboratory plasma glucose or blood gas analyser when this will not delay treatment. Staff should record the sample type, device, time, relation to feeding and any intervention given.

Acting On Low Results

A protocol should use operational thresholds that match current state, territory or institutional guidance. Numeric cut-offs can differ according to age after birth, symptoms and whether the value is a screening measurement or a laboratory result. Publishing one universal number without context can encourage either false reassurance or unnecessary treatment.

For an asymptomatic infant with a mildly low reading, the usual response may include warmth, an effective breastfeed, expressed colostrum or a measured supplemental feed, followed by a repeat glucose check. Buccal dextrose gel is used in many Australian services as an adjunct to feeding for selected well babies. It should be administered according to the local product protocol, with attention to gestation, dose, feeding support and repeat testing.

Symptoms change the urgency. A newborn with seizures, apnoea, marked lethargy, cyanosis or inability to feed should not wait through several attempts at oral treatment. The team should provide immediate glucose according to neonatal guidelines, monitor cardiorespiratory status and investigate contributing conditions. Sepsis, hypothermia, polycythaemia, endocrine disorders and inborn errors of metabolism may need consideration when hypoglycaemia is severe, persistent or recurrent.

Feeding Support And Dextrose Therapy

A strong screening pathway protects breastfeeding rather than treating it as separate from glucose management. Nurses, midwives and lactation consultants can observe a feed, help with positioning and arrange hand expression or pumping. Families often understand plain language such as “we need to check the bub’s sugar before the next feed”, provided staff explain what the number means and what will happen next.

If enteral feeding is inadequate or unsafe, intravenous dextrose may be required. The concentration, starting rate, access requirements and adjustment schedule must follow the neonatal unit’s approved guideline. A baby needing escalating glucose delivery should prompt review of the diagnosis rather than repeated automatic increases alone. Intravenous access, fluid balance and the risk of extravasation require careful nursing oversight.

Parents should be told whether the low reading was confirmed, whether their baby had symptoms and whether treatment is expected to be brief. They should receive a consistent explanation from the maternity and neonatal teams, especially when care crosses from a postnatal ward to a special care nursery. This is particularly important in private hospitals, where families may move between obstetric, paediatric and visiting medical teams.

Reviewing Protocol Performance

A written policy is only effective when the bedside workflow is reliable. Staff need easy access to the screening chart, clear instructions for meter quality control and a process for recording missed checks. Education should cover sample collection, feeding assistance, dextrose gel, escalation and documentation rather than focusing on thresholds alone.

Audits can examine the percentage of eligible infants screened on time, the frequency of repeat testing after a low result, delays to treatment, unplanned neonatal admissions and the proportion of babies receiving formula when other options were available. Results should be reviewed by the maternity and neonatal governance groups, with attention to equity for Aboriginal and Torres Strait Islander families, rural communities and parents who need an interpreter.

Local services can also compare outcomes with state-wide neonatal networks and current Australian guidance, while recognising that a tertiary centre’s resources may not be available in a remote hospital. A sensible protocol includes a telephone escalation route, retrieval criteria and a plan for transferring laboratory results and feeding information. Simulation training using realistic cases can reveal gaps before they affect a newborn.

A safe approach to neonatal glucose monitoring begins with identifying risk, offering timely feeding and measuring accurately. It then continues through prompt treatment, confirmation of unexpected results and specialist review when low glucose does not resolve. Review your maternity or neonatal unit’s current pathway against these principles, make the escalation contacts visible at every cot side and ensure every member of the team can explain the plan clearly to families.